A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth.
Sara HellströmAndrea JonsdotterMaria JonssonKarin PetterssonSissel SaltvedtAndreas HerbstJohan ÅgrenUlrika ÅdénMagnus DomellöfHenrik HagbergYlva CarlssonPublished in: Acta obstetricia et gynecologica Scandinavica (2023)
treatment, but the a priori target of 90% was not reached during the first year of implementation. Our findings indicate that this target could be reached with additional information to clinicians.